Irritable bowel syndrome diagnosis and management: a simplified algorithm for clinical practice

P Moayyedi, F Mearin, F Azpiroz… - United European …, 2017 - journals.sagepub.com
Background Effective management of irritable bowel syndrome (IBS), a common functional
gastrointestinal disorder, can be challenging for physicians because of the lack of simple …

[HTML][HTML] The dietary management of patients with irritable bowel syndrome: a narrative review of the existing and emerging evidence

J Algera, E Colomier, M Simrén - Nutrients, 2019 - mdpi.com
Even though irritable bowel syndrome (IBS) has been known for more than 150 years, it still
remains one of the research challenges of the 21st century. According to the current …

[HTML][HTML] Management of functional gastrointestinal disorders

A Fikree, P Byrne - Clinical Medicine, 2021 - Elsevier
Functional gastrointestinal (GI) disorders (eg irritable bowel syndrome and functional
dyspepsia) are very common conditions which are associated with very poor quality of life …

New treatments and therapeutic targets for IBS and other functional bowel disorders

M Simrén, J Tack - Nature Reviews Gastroenterology & Hepatology, 2018 - nature.com
Functional bowel disorders (FBDs) are a spectrum of disorders characterized by
combinations of symptoms attributable to the lower gastrointestinal tract. Most current first …

Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights

SW Kinsinger - Psychology research and behavior management, 2017 - Taylor & Francis
Irritable bowel syndrome (IBS) is a chronic gastrointestinal (GI) condition associated with
significant health care utilization and quality-of-life impairment. Latest research indicates that …

Cumulative effects of psychologic distress, visceral hypersensitivity, and abnormal transit on patient-reported outcomes in irritable bowel syndrome

M Simrén, H Törnblom, OS Palsson, L Van Oudenhove… - Gastroenterology, 2019 - Elsevier
Background & Aims Little is known about the link between pathophysiologic factors and
symptoms of irritable bowel syndrome (IBS), or whether these factors have cumulative …

Epidemiologic burden and treatment of chronic symptomatic functional bowel disorders in the United States: a nationwide analysis

C Ma, SE Congly, KL Novak, PJ Belletrutti, M Raman… - Gastroenterology, 2021 - Elsevier
Background & Aims Functional bowel disorders (FBDs) are the most common
gastrointestinal problems managed by physicians. We aimed to assess the burden of …

Cumulative effect of psychological alterations on gastrointestinal symptom severity in irritable bowel syndrome

I Midenfjord, A Borg, H Törnblom… - Official journal of the …, 2021 - journals.lww.com
METHODS: Patients with IBS (Rome IV) completed validated questionnaires assessing GI
symptoms (Gastrointestinal Symptom Rating Scale, IBS version and IBS Severity Scoring …

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population

NT Tornkvist, I Aziz, WE Whitehead, AD Sperber… - UEG …, 2021 - Wiley Online Library
Background Irritable bowel syndrome (IBS) is highly prevalent worldwide but mechanisms
for healthcare seeking behaviours in this patient group are poorly understood. Objective To …

Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial

L Decraecker, D De Looze, DP Hirsch, H De Schepper… - Gut, 2024 - gut.bmj.com
Objective We evaluated the histamine 1 receptor antagonist ebastine as a potential
treatment for patients with non-constipated irritable bowel syndrome (IBS) in a randomised …